Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pars Minoo Pharmaceutical and Cosmetic Company is a prominent Iranian manufacturer of pharmaceuticals, cosmetics, and food products, headquartered in Tehran. Established in 1959, it is a key subsidiary of the Minoo Industrial Group and stands as one of the most established healthcare entities in the Middle East. The company's pharmaceutical division focuses on the production of a diverse range of generic medicines, including analgesics, antibiotics, and cardiovascular treatments. Pars Minoo maintains significant manufacturing capabilities, including GMP-certified facilities for tablets, capsules, and liquid formulations. The company is publicly traded on the Tehran Stock Exchange and serves both domestic and international markets with a broad portfolio of healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pars Mino.